The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarrs Group Regulatory News (CARR)

Share Price Information for Carrs Group (CARR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 134.00
Bid: 131.50
Ask: 135.00
Change: 0.00 (0.00%)
Spread: 3.50 (2.662%)
Open: 134.00
High: 0.00
Low: 0.00
Prev. Close: 134.00
CARR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Carr's Group (CARR): Optimising value for shareholders

9 Feb 2022 07:00

Edison Investment Research Limited Carr's Group (CARR): Optimising value for shareholders 09-Feb-2022 / 07:00 GMT/BST


 

London, UK, 9 February 2022

 

Carr's Group (CARR): Optimising value for shareholders

Over several decades Carr's Group has diversified both within and outside the UK agricultural market. This has reduced the group's exposure to the vagaries of the British climate, farming policy and volatile commodity prices and taken it into activities that generate substantially higher margins and present opportunities for stronger growth than the traditional agriculture sector in individual countries. However, while the board sees potential for growth in each of the three divisions, there are limited opportunities to exploit inter-divisional synergies, so it has announced a strategic review.

 

Our DCF analysis gives an indicative value of 170p/share (unchanged). Given the ongoing strategic review, a sum-of-the-parts (SOTP) analysis is more appropriate as this recognises that stocks engaged purely in engineering activities or providing speciality agricultural inputs command substantially higher multiples than those involved in supplying commoditised agricultural inputs. Our SOTP calculation gives a value of 292.7p/share, suggesting that any potential strategic activity that released the value of individual divisions by splitting up the group would be beneficial for shareholders.

Click here to view the full report or here to sign up to receive research as it is published.

 

All reports published by Edison are available to download free of charge from its website

www.edisongroup.com

About Edison: Edison is a leading research and investor relations consultancy, connecting listed companies to the widest pool of global investors. By focusing on the volume and quality of investors reached - across institutions, family offices, wealth managers and retail investors - Edison can create and gauge intent to purchase, even in the darkest pools of capital, and then make introductions via non-deal roadshows, events or virtual meetings.

Having been the first in-market 17 years ago, Edison now has more than 100 analysts covering every economic sector. Headquartered in London, Edison also has offices in New York, Frankfurt, Amsterdam and Tel Aviv and a presence in Athens, Johannesburg and Sydney.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information, please contact Edison:

Anne Margaret Crow +44 (0)20 3077 5700 industrials@edisongroup.com

Learn more at www.edisongroup.com and connect with Edison on:

LinkedIn www.linkedin.com/company/edison-group-/

Twitter  www.twitter.com/Edison_Inv_Res

YouTube www.youtube.com/edisonitv


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

1277981 09-Feb-2022 

corporate announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
24th Apr 202410:31 amRNSReplacement: Strategic Update and Interim Results
18th Apr 20247:00 amRNSStrategic Update and Interim Results
15th Apr 202411:45 amRNSAppointment of Joint Corporate Broker
9th Apr 20247:00 amRNSTotal Voting Rights
7th Mar 202412:57 pmRNSTotal Voting Rights
22nd Feb 202412:40 pmRNSTotal Voting Rights
21st Feb 20242:58 pmRNSResult of Annual General Meeting 2024
31st Jan 20241:36 pmRNSBlocklisting Application
29th Jan 20249:48 amRNSDirector/PDMR Shareholding
24th Jan 20247:00 amRNSDirector/PDMR Shareholding
24th Jan 20247:00 amRNSDirector/PDMR Shareholding
16th Jan 202410:15 amRNSHolding(s) in Company
15th Jan 20243:13 pmRNSHolding(s) in Company
10th Jan 20245:29 pmRNSNotice of AGM 2024 and 2023 Annual Report
9th Jan 202412:43 pmRNSHolding(s) in Company
2nd Jan 20247:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
2nd Jan 20247:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
27th Dec 20237:22 amRNSPublication of Annual Report and Accounts 2023
21st Dec 20237:00 amRNSFull Year Results
13th Dec 20231:03 pmRNSNotice of Results
13th Nov 20237:00 amRNSLeadership Changes and Notice of Results
1st Nov 20233:22 pmRNSOutcome of Shareholder Engagement
16th Oct 20232:13 pmRNSHolding(s) in Company
10th Oct 20237:00 amRNSTrading Update
6th Oct 20234:09 pmRNSNon-Executive Director Succession
2nd Oct 20239:44 amRNSHolding(s) in Company
31st Aug 20239:52 amRNSTotal Voting Rights
16th Aug 20234:24 pmRNSDirector/PDMR Shareholding
7th Aug 20237:00 amRNSCEO succession
4th Aug 20237:00 amRNSTrading Update
18th Jul 20239:07 amRNSHolding(s) in Company
7th Jul 20239:50 amRNSDirector/PDMR Shareholding
6th Jul 202312:40 pmRNSBLOCK LISTING SIX MONTHLY RETURN
6th Jul 202312:39 pmRNSBLOCK LISTING SIX MONTHLY RETURN
4th Jul 20234:48 pmRNSDirector/PDMR Shareholding
30th Jun 20239:44 amRNSTotal Voting Rights
13th Jun 202312:11 pmRNSHolding(s) in Company
31st May 20234:50 pmRNSTotal Voting Rights
23rd May 20231:01 pmRNSHolding(s) in Company
19th May 202312:57 pmRNSDirector/PDMR Shareholding
16th May 20231:32 pmRNSDirector/PDMR Shareholding
16th May 20239:20 amRNSDirector/PDMR Shareholding
5th May 20231:26 pmRNSDirector/PDMR Shareholding
5th May 20239:23 amRNSDirector/PDMR Shareholding
5th May 20239:22 amRNSDirector/PDMR Shareholding
4th May 20236:00 pmRNSReplacement: Holding(s) in Company
2nd May 20235:36 pmRNSReplacement: Total Voting Rights
2nd May 20233:09 pmRNSResult of General Meeting 2 May 2023
2nd May 202312:41 pmRNSHolding(s) in Company
2nd May 20237:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.